Actively Recruiting

Phase Not Applicable
Age: 10Years - 14Years
All Genders
ID06275412

Family mHealth Intervention to Improve Health Outcomes in Black Youth With Type 1 Diabetes

Led by Wayne State University · Updated on 2025-07-15

216

Participants Needed

4

Research Sites

N/A

Total Duration

On this page

Sponsors

W

Wayne State University

Lead Sponsor

N

National Institute on Minority Health and Health Disparities (NIMHD)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the effectiveness of The 3Ms 2.0, a mobile health (mHealth) family intervention, compared to an educational control for improving blood sugar control and family relationships related to diabetes among Black adolescents aged 10 to 14 years with type 1 diabetes and their primary caregivers. This multi-center randomized controlled trial aims to reduce caregiver distress and enhance diabetes management through culturally tailored content delivered via mobile devices. Participants will be randomly assigned to receive either The 3Ms 2.0 intervention or an educational attention control, both alongside standard medical care. The 3Ms 2.0 program includes three brief computer-delivered sessions for caregivers, featuring interactive narration, skill demonstration videos, and text reminders over a three-month period, with follow-ups accessible monthly. The control group will also receive three informational sessions on diabetes-related topics within a six-month access window. Families will provide data at home or online at baseline, 3 months, 6 months, and 12 months after starting. Assessments include questionnaires on diabetes management, parental supervision, family dynamics, and quality of life, along with blood samples to measure HbA1c for blood sugar levels and medical record reviews. The study will analyze all participants' data regardless of intervention completion to evaluate the impact on glycemic control and family well-being over one year.

CONDITIONS

Brief Title

Family Intervention for Black Teens With Type 1 Diabetes

Who Can Participate

Age: 10Years - 14Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 10 years, 0 months and 14 years, 11 months
  • Diagnosed with Type 1 diabetes for at least 6 months
  • Identifies as Black
  • Primary caregiver willing to participate
  • Lives within 30 miles of a recruitment site
  • Caregiver owns an internet-enabled device such as a cell phone, laptop, desktop, or tablet
Not Eligible

You will not qualify if you...

  • Mental health conditions that could affect data quality, including developmental delay, schizophrenia, psychosis, current suicidality, or homicidality
  • Co-existing medical conditions causing unusual diabetes management, such as cystic fibrosis
  • Inability to speak or read English
  • Child is in out-of-home placement

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote)

Treatment

Duration - 6 months

Participants receive either The 3Ms 2.0 mHealth intervention or an educational attention control condition, both delivered via mobile device, alongside standard medical care.

Data collection at baseline, 3 months, and 6 months; intervention sessions accessible during this time

Follow-up

Duration - 6 months after treatment ends

Participants complete additional assessments 12 months after baseline to evaluate longer-term outcomes.

1 visit (in-person or remote) at 12 months post-baseline

Trial Site Locations

Total: 4 locations

1

Children's National Hospital

Washington D.C., District of Columbia, United States, 20010

Actively Recruiting

2

Wayne Pediatrics

Detroit, Michigan, United States, 48201

Actively Recruiting

3

LeBonheur Children's Hospital

Memphis, Tennessee, United States, 38103

Actively Recruiting

4

University of Tennessee Health Science Center-Memphis

Memphis, Tennessee, United States, 38163

Actively Recruiting

Loading map...

Research Team

D

Deborah A Ellis, Ph.D.

J

Jillian T Sjostrom, B.S.

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Fully Closed-Loop Glucose Control in Adults With Type 1 Diab...

Type 1 Diabetes

Actively Recruiting

4 locations

TEPLIzumab: Quality of Life Evaluation During Stage Transiti...

Type 1 Diabetes

Actively Recruiting

1 location

A National Screening Program for Islet Autoantibodies Among ...

Type 1 Diabetes

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here